ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 640,09
0,68%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aadi Bioscience Inc (AADI)

  7. Aadi Bioscience Inc (AADI) Actualités

AADI

Aadi Bioscience (AADI)

Aadi Bioscience Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AADI
DateHeureSourceTitreSymboleSociété
14/06/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
12/06/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
03/06/202418h26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AADIAadi Bioscience Inc
29/05/202422h05PR Newswire (US)Aadi Bioscience to Participate in the Jefferies Healthcare ConferenceNASDAQ:AADIAadi Bioscience Inc
23/05/202423h30PR Newswire (US)Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:AADIAadi Bioscience Inc
08/05/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AADIAadi Bioscience Inc
08/05/202414h00PR Newswire (US)Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
01/05/202414h01PR Newswire (US)Aadi Bioscience to Report First Quarter 2024 Results and Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
09/04/202414h00PR Newswire (US)Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:AADIAadi Bioscience Inc
17/03/202413h00PR Newswire (US)Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)NASDAQ:AADIAadi Bioscience Inc
13/03/202413h00PR Newswire (US)Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
06/03/202414h00PR Newswire (US)Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
05/03/202422h30PR Newswire (US)Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:AADIAadi Bioscience Inc
01/03/202422h08PR Newswire (US)Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComaNASDAQ:AADIAadi Bioscience Inc
26/02/202422h05PR Newswire (US)Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:AADIAadi Bioscience Inc
12/02/202423h21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AADIAadi Bioscience Inc
12/02/202423h16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AADIAadi Bioscience Inc
26/01/202422h05PR Newswire (US)Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers SymposiumNASDAQ:AADIAadi Bioscience Inc
19/01/202422h05PR Newswire (US)Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers SymposiumNASDAQ:AADIAadi Bioscience Inc
14/12/202322h05PR Newswire (US)Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating AlterationsNASDAQ:AADIAadi Bioscience Inc
08/11/202322h28Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AADIAadi Bioscience Inc
08/11/202314h00PR Newswire (US)Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
06/11/202322h05PR Newswire (US)Aadi Bioscience to Participate in Jefferies London Healthcare ConferenceNASDAQ:AADIAadi Bioscience Inc
01/11/202321h05PR Newswire (US)Aadi Bioscience to Report Third Quarter 2023 Results and Operational UpdateNASDAQ:AADIAadi Bioscience Inc
19/10/202322h05PR Newswire (US)Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global MeetingNASDAQ:AADIAadi Bioscience Inc
12/10/202322h05PR Newswire (US)Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:AADIAadi Bioscience Inc
05/10/202322h05PR Newswire (US)Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical SymposiumNASDAQ:AADIAadi Bioscience Inc
04/10/202300h47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
03/10/202322h05PR Newswire (US)Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)NASDAQ:AADIAadi Bioscience Inc
02/10/202314h00PR Newswire (US)Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive OfficerNASDAQ:AADIAadi Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:AADI

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
EU
MC
Lvmh Moet Hennessy Louis...
EU
CAP
Capgemini
EU
EN
Bouygues
EU
RNO
Renault
COIN
ETHUSD
Ethereum
EU
VK
Vallourec
FTSE
UKX
FTSE 100
NYSE
MRK
Merck
EU
GLE
Societe Generale
NYSE
JPM
JP Morgan Chase
NYSE
KO
Coca Cola
EU
LR
Legrand
NASDAQ
NVDA
NVIDIA
EU
PX4
SBF 120
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés